NO156153C - Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering. - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering.

Info

Publication number
NO156153C
NO156153C NO810062A NO810062A NO156153C NO 156153 C NO156153 C NO 156153C NO 810062 A NO810062 A NO 810062A NO 810062 A NO810062 A NO 810062A NO 156153 C NO156153 C NO 156153C
Authority
NO
Norway
Prior art keywords
preparing
procedure
long
pharmaceutical preparation
term release
Prior art date
Application number
NO810062A
Other languages
English (en)
Norwegian (no)
Other versions
NO156153B (no
NO810062L (no
Inventor
James Michael Dunn
John Francis Lampard
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of NO810062L publication Critical patent/NO810062L/no
Publication of NO156153B publication Critical patent/NO156153B/no
Publication of NO156153C publication Critical patent/NO156153C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO810062A 1980-01-11 1981-01-09 Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering. NO156153C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (3)

Publication Number Publication Date
NO810062L NO810062L (no) 1981-07-13
NO156153B NO156153B (no) 1987-04-27
NO156153C true NO156153C (no) 1987-08-05

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810062A NO156153C (no) 1980-01-11 1981-01-09 Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering.

Country Status (22)

Country Link
JP (1) JPS56103110A (fi)
AT (1) AT374681B (fi)
AU (1) AU542824B2 (fi)
BE (1) BE886998A (fi)
CA (1) CA1140466A (fi)
CH (1) CH646604A5 (fi)
DE (1) DE3100191A1 (fi)
DK (1) DK6181A (fi)
ES (2) ES498369A0 (fi)
FI (1) FI76927C (fi)
FR (1) FR2473308B1 (fi)
GB (1) GB2067072B (fi)
GR (1) GR73843B (fi)
IE (1) IE50806B1 (fi)
IN (1) IN151913B (fi)
IT (1) IT1221041B (fi)
LU (1) LU83052A1 (fi)
NL (1) NL8100037A (fi)
NO (1) NO156153C (fi)
NZ (1) NZ195933A (fi)
SE (1) SE447450B (fi)
ZA (1) ZA81136B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
EP0230647B1 (en) * 1985-12-27 1993-03-31 Sumitomo Pharmaceuticals Company, Limited Method for producing a sustained release formulation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CA1316110C (en) * 1987-02-27 1993-04-13 Peter Lloyd Oren Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (fi) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
AU6597681A (en) 1981-07-16
NL8100037A (nl) 1981-08-03
NZ195933A (en) 1982-11-23
JPS56103110A (en) 1981-08-18
ATA5481A (de) 1983-10-15
IE810036L (en) 1981-07-11
DE3100191C2 (fi) 1988-09-01
SE8100104L (sv) 1981-07-12
FI76927C (fi) 1989-01-10
ES8205353A1 (es) 1982-06-01
FI76927B (fi) 1988-09-30
AU542824B2 (en) 1985-03-14
DK6181A (da) 1981-07-12
BE886998A (fr) 1981-07-08
ES8301629A1 (es) 1982-12-16
FR2473308A1 (fr) 1981-07-17
LU83052A1 (fr) 1982-09-10
IN151913B (fi) 1983-09-03
GB2067072A (en) 1981-07-22
DE3100191A1 (de) 1981-12-10
NO156153B (no) 1987-04-27
AT374681B (de) 1984-05-25
ZA81136B (en) 1982-01-27
CH646604A5 (fr) 1984-12-14
IE50806B1 (en) 1986-07-23
IT8147537A0 (it) 1981-01-09
IT1221041B (it) 1990-06-21
NO810062L (no) 1981-07-13
GB2067072B (en) 1983-08-10
FI810056L (fi) 1981-07-12
ES509179A0 (es) 1982-12-16
SE447450B (sv) 1986-11-17
GR73843B (fi) 1984-05-07
FR2473308B1 (fr) 1985-07-19
CA1140466A (en) 1983-02-01
ES498369A0 (es) 1982-06-01

Similar Documents

Publication Publication Date Title
DK221281A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forbedrede frigivelsesegenskaber
NO812827L (no) Fremgangsmaate for fremstilling av et bacampicillinpreparat
FI801876A (fi) Farmaceutiska preparat
NO885641L (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat.
NO167674C (no) Fremgangsmaate for fremstilling av et plasmid.
DK146677A (da) Fremgangsmade til fremstilling af et farmaceutisk preparat indeholdende triazolopyrimidin
NO781079L (no) Preparat med regulert medikamentfrigjoering
NO882103L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO157048C (no) Fremgangsmaate til fremstilling av en tablett.
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK154282A (da) Fremgangsmaade til fremstilling af et varmeisoleret ledningsroer
NO800186L (no) Fremstilling av et medisinsk preparat.
NO159341C (no) Fremgangsmaate for fremstilling av en farvet, fast gjenstand.
NO156153C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering.
NO870368D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig virkning.
FI822187A0 (fi) Farmaceutiska preparat
DK98076A (da) Fremgangsmade til fremstilling af et farmaceutisk preparat
DK155082A (da) Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning
DK206582A (da) Fremgangsmaade til fremstilling af et furanderivat
DK56480A (da) Fremgangsmaade til fremstilling af et kombinationsemne
FI810874L (fi) Farmaceutiska preparat
DK155976C (da) Fremgangsmaade til fremstilling af en tablet med langvarig frigoerelsesvirkning
DK457680A (da) Fremgangsmaade til fremstilling af et urinstofderivat
DK89280A (da) Fremgangsmaade til fremstilling af et carbazolderivat
IT8123492A0 (it) Preparato farmaceutico di nicomol a emissione controllata.